TrialHuman gene therapy2008

Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2.

Bianca Heemskerk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.